Xencor Quarterly Cash Flow Statement
NASDAQ: XNCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
24.63+0.13 (+0.53%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Xencor free cash flow
In the quarter ended Jun 30, 2026, Xencor generated -$55.7 million of operating cash flow and spent $538,000 on capital expenditures. That left free cash flow of -$56.2 million, a free-cash-flow margin of -109.7% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Xencor cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -21.73M | -128.92M | -6.65M | -6.03M | -30.82M | -48.63M | -46.20M | -47.44M | -68.78M | -74.12M | -26.31M | -24.27M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 2.44M | 2.57M | 2.58M | 2.59M | 2.65M | 2.69M | 2.99M | 3.05M | 3.02M | 3.04M | 3.23M | 3.14M |
| Stock-Based Compensation | 9.19M | 9.56M | 10.19M | 10.09M | 10.74M | 12.21M | 12.33M | 12.34M | 17.19M | 11.42M | 14.70M | 12.90M |
| Change in Working Capital | -21.02M | 57.00K | 9.31M | 26.00K | -159.00K | 24.74M | -8.37M | 14.02M | -988.00K | -6.00M | -7.67M | 8.72M |
| Operating Cash Flow | -55.66M | -67.63M | -51.71M | -30.82M | -36.37M | -16.22M | -49.84M | -28.14M | -67.35M | -56.86M | 18.17M | -27.28M |
| Capital Expenditures | -538.00K | -610.00K | -1.14M | -183.00K | -383.00K | -1.44M | -1.66M | -1.27M | -3.03M | -132.00K | -980.00K | -2.83M |
| Investing Cash Flow | 85.12M | 26.68M | 71.17M | 14.67M | 40.48M | 13.67M | 57.25M | -163.46M | 66.02M | 32.32M | -203.13M | 45.33M |
| Financing Cash Flow | 1.03M | 950.00K | 6.32M | 0 | 662.00K | 1.25M | 4.43M | 189.86M | 1.07M | 1.79M | 186.02M | 356.00K |
| Net Change in Cash | 30.49M | -40.00M | 25.78M | -16.15M | 4.77M | -1.30M | 11.85M | -1.74M | -264.00K | -22.75M | 1.06M | 18.40M |
| Free Cash Flow | -56.20M | -68.24M | -52.85M | -31.00M | -36.75M | -17.66M | -51.50M | -29.42M | -70.38M | -56.99M | 17.19M | -30.11M |
This table shows 12 quarterly periods of Xencor's cash flow statement, from Q2 2026 back to Q3 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow XNCR's reporting calendar. What is a cash flow statement?